Navigation Links
Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
Date:3/3/2008

SOPHIA ANTIPOLIS, France, March 3 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today announced its financial results for 2007 and provided an overview of its activities during the year. NicOx also announced today the initiation of two large Ambulatory Blood Pressure Monitoring (ABPM) studies for naproxcinod (see separate press release).

Key highlights 2007:

-- Initiation of the two remaining pivotal phase 3 trials for naproxcinod

(the 302 and 303 studies) and completion of enrollment in the 302 study

-- Presentation of the naproxcinod phase 3 results at the American College

of Rheumatology (the 301 study) and data from an Ambulatory Blood

Pressure Monitoring trial at the American Heart Association (the 104

study)

-- Initiation of a phase 2 proof-of-concept study designed to compare the

safety and efficacy of PF-03187207 to Pfizer Inc's Xalatan

-- Start of clinical development for the first nitric oxide-donating

antihypertensive by Merck & Co., Inc.

-- Initiation of a phase 2 proof-of-concept study for TPI 1020 in Chronic

Obstructive Pulmonary Disease (COPD), following promising top-line

results in a phase 2a study in asthmatic smokers

-- Establishment of NicOx' United States (U.S.) headquarters in Warren,

New Jersey, as a base for Commercial Affairs and Clinical Operations in

North America

-- Strengthening of the Company's executive management team, through the

appointment of Pascal Pfister, MD as Chief Scientific Officer (CSO),

and Sanjiv Sharma as Vice President Commercial Affairs

"We envision that 2008 will be a transformational year for NicOx. We expect to complete the pivotal phase 3 program for naproxcinod, including a pooled analysis of the Office Blood Pressure Measurements, ahead of a projected New Drug Application filing in mid-2009," said Michele Garufi, Chair
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
3. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
4. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
5. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
6. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
7. Biopure Announces 2007 Third Quarter Financial Results
8. Xytis Names Gordon H. Busenbark as Chief Financial Officer
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Pharmacopeia Announces Third Quarter 2007 Financial Results
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Eli Lilly and Company (NYSE: LLY ) today ... its intent to end its contract with the university ... Alzheimer,s disease (A4) study. The A4 study is a ... of Alzheimer,s disease in older individuals who have evidence ... but do not show symptoms of memory impairment. A4 ...
(Date:8/4/2015)... , Aug. 4, 2015  IRIDEX Corporation (Nasdaq: ... Mackaness , who had served as chief financial officer ... has resigned his positions with the Company, effective August ... at another company. Mr. Mackaness intends to continue to ... quarter earnings announcement and 10-Q filing. ...
(Date:8/4/2015)... 2015 Governor Tom Wolf announced today ... and markets implants in the spine and trauma markets, will ... , Northampton County to serve as ... create 25 new, full-time jobs. "Tyber Medical,s ... create more than two dozen, high-paying jobs is great news ...
Breaking Medicine Technology:Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity 2Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 2Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 3
... The Michael J. Fox Foundation awarded a total of ... pre-clinical research on potential new treatments for Parkinson,s disease.The ... Initiative. This program, first launched in 2006, supports ... is part of MJFF,s focus on ...
... Jan. 6 Pacira Pharmaceuticals, Inc., an,acute care ... completed in two pivotal Phase III SIMPLE trials ... intraoperative administration of EXPAREL(TM),(DepoBupivacaine) for prolonged postoperative analgesia. ... studies in hemorrhoidectomy and in total knee,arthroplasty (TKA) ...
Cached Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3
(Date:8/4/2015)... , ... August 04, 2015 , ... 24/7 Care ... Los Angeles, Riverside, and San Bernardino, today announced that the U.S. Department of Veteran’s ... that 24/7 Care At Home’s agency is well on the path to meeting the ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... those entering kindergarten. All required immunizations are covered for members under the Healthchek ... children who aren’t caught up with their immunizations may not be allowed to ...
(Date:8/4/2015)... ... August 04, 2015 , ... Discovia, a leading ... announced that John Munro, a 15-year veteran of the eDiscovery services industry, has ... , “I am thrilled to join Discovia at this important point in its ...
(Date:8/4/2015)... St. Louis, Missouri (PRWEB) , ... August 04, ... ... Automated Texting (IAT) solutions, today announced that Bruce McCalley joins its executive leadership ... 30-year track record of sales success at technology companies and expanding global markets ...
(Date:8/4/2015)... ... August 04, 2015 , ... Mesothelioma ... has come back: Retreatment may be a viable option. Surviving Mesothelioma has just ... , According to surgeons at the University of New South Wales, ...
Breaking Medicine News(10 mins):Health News:24/7 Care At Home Receives Two Stars from the VA 2Health News:24/7 Care At Home Receives Two Stars from the VA 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 3Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3Health News:New Research Reveals Some Patients Experience Extended Mesothelioma Survival with Repeat Treatment, According to Surviving Mesothelioma 2
... Function Drinks,announced today the launch of their ... on supporting sexual health. Function: Night Life ... amino acid, tyrosine, to provide,the building blocks ... with reward and desire. Epimedium, niacin and,cnidium ...
... for ... consumers, PRINCETON, N.J., June ... care products,announced today that its key product line, MEDIHONEY(TM) Wound & Burn,Dressings ... counter (OTC) sales. This will provide consumers with expanded,access to the products ...
... Kiner has,been named vice president and general manager ... In this new role, Stewart is responsible for,providing ... senior market lines of business, including Medicare Advantage ... Kiner will report to,Karen Vigil, senior vice president ...
... 24 Speaker Nancy Pelosi,issued the following statement ... Act, which passed the House this afternoon by ... bipartisan and veto-proof vote sends a strong signal ... for providers will not,be held hostage to the ...
... Zuccari,President & CEO of Hamilton Insurance Agency is featured ... Health Care Association this,June for his recent work with ... by the AHCA," said Alan J. Zuccari. "I,am proud ... focus is providing quality care.", Below is the ...
... supply, study suggests , , TUESDAY, June 24 (HealthDay News) ... help reduce a form of brain injury that affects ... study. , Hypoxic-ischemia, a compromise of the brain,s ... and cognitive/behavioral problems. , In experiments with rats that ...
Cached Medicine News:Health News:Function Drinks Launches New Product to Support Sexual Health 2Health News:Derma Sciences Receives FDA Clearance to Sell MEDIHONEY(TM) Over the Counter 2Health News:Derma Sciences Receives FDA Clearance to Sell MEDIHONEY(TM) Over the Counter 3Health News:Blue Shield of California Appoints Industry Veteran as New Vice President and General Manager for Senior Market 2Health News:Alan J. Zuccari Featured by the American Health Care Association as a June PAC Member 2Health News:Alzheimer's Drug May Reduce Preemie Brain Injury 2
All metal for storing 5 cm x 5 cm (2 inches x 2 inches) 35 mm color slides. Each is individually crafted of high grade steel and finished with a durable baked enamel finish....
It's a slide cabinet system, store up to 54,000 slides in only 2 square feet of space. Ideal for use in Pathology, Cytology, Hematology, Histology, Dermatology, Research, Education....
A slide filing system, allows for the convenient storage and retrieval of microscope slides or transparencies. Requires only 48 cm x 48 cm (19 inches x 19 inches) of floor space....
Unit System Slide Cabinet is constructed from hardwood for long lasting....
Medicine Products: